Drugs Information: Pegvisomant
Basic Information
|
||
| ID | DDInter1412 | |
| Drug Type | biotech | |
| Molecular Formula | C990H1532N262O300S7 | |
| Molecular Weight | - | |
| Description | Pegvisomant is a highly selective growth hormone (GH) receptor antagonist. It is used to treat acromegaly. Unlike dopamine or somatostatin analogs (which inhibit growth hormone secretion), this drug actually blocks the hepatic (GH-mediated) production of insulin like growth factor (IGF-1), which is the main mediator of growth hormone activity. | |
| ATC Classification | H01AX01 | |
| IUPAC Name | None | |
| InChI | None | |
| InChI Key | None | |
| Canonical SMILES | None | |
| Useful Links | DrugBank | |
Interactions with Pegvisomant
| Severity level | ID | Name | Mechanism | Detail |
|---|